Close
  Indian J Med Microbiol
 

Figure 1: Effect of advanced glycation end products (AGEs) on chondrocytes viability. This data were compared between no treatment group, AGEs group and AGEs+raspamycin group. *P<0.05, **P;<0.01 and #P<0.001.

Figure 1: Effect of advanced glycation end products (AGEs) on chondrocytes viability.
This data were compared between no treatment group, AGEs group and AGEs+raspamycin group. *<i>P</i><0.05, **<i>P</i>;<0.01 and #<i>P</i><0.001.